The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 110.50
Ask: 112.00
Change: 0.50 (0.45%)
Spread: 1.50 (1.357%)
Open: 109.50
High: 113.00
Low: 109.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Jan 2018 07:00

RNS Number : 1627B
McBride PLC
08 January 2018
 

8 January 2018

 

McBride plc

Trading Update

 

McBride plc, the leading European manufacturer and supplier of Co-manufactured and Private Label products for the Household and Personal Care market, provides its trading update for the six months ended 31 December 2017.

The Group starts its second half year with Household sales growth prospects significantly ahead of expectations but at the same time facing weak trading in the European Personal Care & Aerosols division ("PCA") and ongoing cost inflation in the near term. The combination of these factors means that the Board now expects full year earnings to be broadly in line with the prior year.

For the first half year, Group revenues at constant currency declined 0.6%. Excluding sales from Danlind, which was acquired at the end of September, underlying Household revenues were 3.4% lower versus the same period last year, with growth in the UK and South regions offset by ongoing decline in France and the negative impact in Germany of the previously-disclosed major contract loss. This reduction in revenues is now expected to be more than reversed during the second half year.

Trading at our European PCA division has been more challenging in the period and revenues declined 12.1%, approximately half of which was due to deliberate management actions to exit certain customer and product arrangements. As previously stated, we are currently developing an accelerated transformation plan for PCA and will provide more information in due course.

The lower sales levels and a number of mainly external cost challenges, including raw materials, labour market pressures and transportation costs, have impacted the Group's first half profit performance, particularly within PCA, such that adjusted operating profit for the first six months of the year will be lower than the Board's prior internal expectations. The revenue and profit performance of Danlind for its first three months as part of the Group have been in line with our expectations at the time of acquisition.

Looking ahead, the Group's growth prospects have been significantly enhanced by recent business wins, mainly arising from competitor weakness, with a number of major customers turning to the Group for support. We anticipate that these opportunities will lead to annualised high-single digit growth for the Household business. These additional sales are anticipated to phase in through the second half of the current financial year and Household is now expected to deliver mid-to-high single digit underlying revenue growth in the second half.

In order to capture this growth opportunity and support our customers, the Group has decided to defer certain efficiency and rationalisation initiatives planned for the current financial year, given the resources required in the near term to meet the anticipated rapid increase in volumes. The combination of the trading performance in the first half, ongoing cost inflation and the operational requirements of accommodating a significant level of new business means that the Group's full year adjusted profit before tax and adjusted EPS are now expected to be broadly in line with the prior year.

Although challenges remain in the European PCA business, we remain pleased with the sustained progress in our Household division, where our "Repair, Prepare, Grow" strategy is now delivering tangible benefits and the Board remains confident in the successful delivery of the Group's strategy.

Rik De Vos, Group Chief Executive, commented;

"Whilst the accelerated growth opportunity we are now seeing is an encouraging validation of the Group's strategy and the positioning of our Household business, the immediate task of accommodating such substantial growth presents challenges and choices.  Despite the near-term margin pressures we are experiencing, we remain focused on delivering our medium-term financial targets and we will re-initiate various efficiency projects once this growth has been absorbed. Additionally, restoring the performance of our PCA business, the plans for which are under consideration, remains a top priority." 

 

For further information please contact:

 

McBride plc

 

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

 

 

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZDLFBVFFEBBQ
Date   Source Headline
5th Jan 20157:00 amRNSTrading Update
18th Dec 20147:00 amRNSBoard Changes
1st Dec 20145:04 pmRNSIssue of B Shares
21st Nov 20149:12 amRNSHolding(s) in Company
11th Nov 201412:46 pmRNSHolding(s) in Company
21st Oct 201410:25 amRNSResult of AGM
20th Oct 20144:08 pmRNSAppointment of Chief Finance Officer
20th Oct 20147:00 amRNSAGM and Interim Management Statement
29th Sep 201412:56 pmRNSDirector/PDMR Shareholding
19th Sep 20147:01 amRNSTotal Voting Rights
19th Sep 20147:00 amRNSAnnual Report and Accounts
15th Sep 201412:25 pmRNSDirector/PDMR Shareholding
11th Sep 20143:24 pmRNSDate of Payments to Shareholders
10th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSAppointment of new Executive Director
8th Jul 20145:00 pmRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Update
2nd Jun 20143:06 pmRNSIssue of B class shares & Total Voting Rights
29th May 20144:32 pmRNSHolding(s) in Company
29th May 20143:50 pmRNSHolding(s) in Company
25th Apr 201412:40 pmRNSHolding(s) in Company
15th Apr 201410:04 amRNSHolding(s) in Company
14th Apr 20149:10 amRNSHolding(s) in Company
9th Apr 20147:00 amRNSCompletion of Refinancing
8th Apr 20144:40 pmRNSDirector/PDMR Shareholding
7th Apr 201411:17 amRNSDirector/PDMR Shareholding
4th Apr 20143:02 pmRNSDirector/PDMR Shareholding
18th Mar 20149:16 amRNSHolding(s) in Company
10th Mar 20144:59 pmRNSDirector Declaration
14th Feb 20149:27 amRNSHolding(s) in Company
11th Feb 20147:00 amRNSForthcoming Directorate Change
11th Feb 20147:00 amRNSHalf Yearly Report
9th Jan 20147:00 amRNSTrading Update
20th Dec 20132:53 pmRNSHolding(s) in Company
20th Dec 20131:29 pmRNSHolding(s) in Company
9th Dec 20138:36 amRNSHolding(s) in Company
3rd Dec 201310:13 amRNSHolding(s) in Company
2nd Dec 20134:31 pmRNSIssue of B Shares
1st Nov 20134:31 pmRNSHolding(s) in Company
1st Nov 20138:47 amRNSHolding(s) in Company
18th Oct 201312:58 pmRNSHolding(s) in Company
15th Oct 201311:24 amRNSResult of AGM
14th Oct 20137:00 amRNSAGM and Interim Management Statement
11th Oct 20139:19 amRNSChange of Registered Office
17th Sep 20133:41 pmRNSDirector/PDMR Shareholding
13th Sep 20139:03 amRNSAnnual Report and Accounts
13th Sep 20139:03 amRNSTotal Voting Rights
4th Sep 20138:56 amRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSFinal Results
5th Jul 20137:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.